Echelon Biosciences Inc.

Salt Lake City, UT Part of Frontier Scientific, Inc.

UEI
EDK8FFD24SC4
CAGE
46MB5
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Porphyrin Products Parent Frontier Scientific, Inc. MDZVFENWKGC4
    • Echelon Biosciences Inc.
SAM.gov registration date
Physical address
675 Arapeen Dr #302, Salt Lake City, UT 84108, USA
Website
echelon-inc.com
Founded
1997
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 -$12,031

Contract awards

Award Agency Obligated Awarded
Custom synthesis of two materials, proposed and approved as an innovation fund project. 13C- hydroxy-IP 85MG… 12905B22P0081 Pacific West Area (FRIID) $11,070
Army sbir phase i W911QY20P0034 ACC Aberdeen Proving Ground $167,500
Transgenic black soldier flies for sustainable, improved nutrition sbir 16.3 phase II 140D6318C0031 Interior Business Center (DO) $1,496,661
"transgenic black soldier flies for sustainable, improved nutrition" IND17PC00157 Interior Business Center (DO) $149,592
Purchase Order HHSN271201500596P National Institute on Drug Abuse (NIH) $11,693

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Award Agency Obligated Awarded
Accessible and robust tools for glycosaminoglycan profiling R43GM131444 National Institute of General Medical Sciences (NIH) $300,000
Targeting ether lipid biosynthesis for disease R43CA189390 National Institutes of Health $224,334
Sbir phase II: near infrared substrates for imaging autotaxin activity in vivo 1127467 National Science Foundation $625,241
New approach to phospholipidosis prediction R43FD004052 Food and Drug Administration $149,884
New approach to phospholipidosis prediction R44FD004052 FDA Office of Acquisition and Grant Services $862,769

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH UEI LAHNMPWWFFJ9 Radeberg, SN 325411 Medicinal and Botanical Manufacturing
BPS Bioscience Inc. UEI ZLDNP9C134F3 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Chem-Master International, Inc. UEI HMB9DMGZBMF3 — 325199 All Other Basic Organic Chemical Manufacturing
Polyorg, Inc. UEI E5VFVSL64RJ8 Leominster, MA 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
Medchemexpress LLC UEI EWMQQNKJ3YZ8 South Brunswick Township, NJ 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Echelon Biosciences Inc. is a global leader in biochemical reagents, assays, and peptides for academic research and pharmaceutical development. The company specializes in custom synthesis and assay development, providing tools and reagents for life science research. It is a for-profit organization that manufactures goods and has been registered in SAM.gov since 2005.

Through federal contract awards, Echelon Biosciences Inc. has provided custom synthesis of materials to the Department of Agriculture Agricultural Research Service. In one instance, it synthesized two materials under an innovation fund project, delivering 13C-hydroxy-IP and 13C-aniline-IPP through a $11,070 purchase order contract. Additionally, the company received a $167,499.96 purchase order contract from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense. This contract was awarded under the Army SBIR (Small Business Innovation Research) Phase I program and set aside for a total small business.

Echelon Biosciences Inc. has also participated in federal grant awards as a sub-awardee. It received a sub-grant from the University of Rochester for a project titled "Neuroprotectant therapeutic interventions to prevent neurological consequences in combat causalities." No further details about the goods or services provided through this grant were available in the provided information.

Quick answers

Is Echelon Biosciences Inc. registered in SAM.gov?

Echelon Biosciences Inc.'s SAM.gov registration expired on June 27, 2026.

What is Echelon Biosciences Inc.'s most recent federal award?

Echelon Biosciences Inc.'s most recent federal contract award is Custom synthesis of two materials, proposed and approved as an innovation fund project. 13C- hydroxy-IP 85MG… (12905B22P0081), from Pacific West Area (FRIID), on March 3, 2022.

On GovTribe

See Echelon Biosciences Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login